Riskpilot← Back to searchSign inGet full accessSPECIALLÆGE TORMOD LABIANCA ApS
APSActiveCVR 25334086Vedbæk Strandvej 445Medical specialists activities · NACE 8622Est. 20001 employees
Revenue 2025
DKK 1,7M
-17% vs 2024
EBITDA margin
38.8%
+3% vs 2024
Equity ratio
66.7%
Financial strength
Net profit 2025
DKK 181K
-41% vs 2024
| Revenue | DKK 1,7M | -17% |
| EBITDA | DKK 651K | +3% |
| Net profit | DKK 181K | -41% |
| Total assets | DKK 2,6M | +2% |
| Equity | DKK 1,7M | +4% |
| Employees | 1 | — |
Legal name
SPECIALLÆGE TORMOD LABIANCA ApS
CVR number
25334086
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
1. april 2000
Share capital
DKK 205.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed, så som ejerskab af fast ejendom og driftsmidler.
Address
Vedbæk Strandvej 445
Phone
+4533137700
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 892 | 1.141 | 1.297 | 2.031 | 1.680 |
| Staff expenses | -909 | -1.062 | -1.051 | -1.397 | -1.029 |
| EBITDA | -17 | 79 | 246 | 634 | 651 |
| Depreciation & amort. | -196 | -187 | -126 | -194 | -178 |
| EBIT | -212 | -108 | 120 | 440 | 473 |
| Net financials | -12 | -18 | -12 | -38 | -24 |
| Profit before tax | -224 | -125 | 108 | 402 | 449 |
| Tax | -48 | -25 | 33 | 95 | 267 |
| Net profit | -176 | -100 | 75 | 307 | 181 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.333 | 2.024 | 1.812 | 2.550 | 2.595 |
| Equity | 1.920 | 1.523 | 1.483 | 1.672 | 1.732 |
| Long-term debt | 0 | 0 | 0 | 348 | 286 |
| Short-term debt | 413 | 502 | 329 | 530 | 522 |
| Total debt | 413 | 502 | 329 | 878 | 808 |
EBITDA margin
38.8%
This company
15.8%
Market median
+146% vs market
20212025
Equity ratio
66.7%
This company
38.2%
Market median
+75% vs market
20212025
Return on equity
10.5%
This company
18.4%
Market median
+43% vs market
20212025
Net profit margin
10.8%
This company
8.1%
Market median
+33% vs market
20212025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20212025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
CE | Audit | 2007 – 2010 |
PA Management | Management | 2000 – 2000 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SPECIALLÆGE TORMOD LABIANCA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Erik Jensen Fuchs | Audit | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |